Skip to main content

Balyasny Asset Management L.P.

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
2,779,445
+211.6% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
1,108,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 1,108,000
2026-03-31 2,779,445
2025-12-31 891,903
2025-03-31 127,887
2024-06-30 19,161
2023-12-31 13,854
2023-06-30 583,651
2023-03-31 367,671
2021-06-30 10,308